Related Experiment Video
Updated: Jun 27, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Staged surgical palliation in hypoplastic left heart syndrome and its variants
Eva Maria B Delmo Walter1, Michael Hübler, Vladimir Alexi-Meskishvili
1Department of Cardiovascular and Thoracic Surgery Deutsches Herzzentrum Berlin, Augustenburger Platz 1, Berlin, Germany. delmo-walter@dhzb.de
Staged palliation for hypoplastic left heart syndrome (HLHS) shows improved outcomes with increased surgical experience. Key factors influencing early mortality in the Norwood procedure include operative weight and cardiopulmonary bypass duration.
Area of Science:
- Pediatric Cardiac Surgery
- Congenital Heart Disease Management
Background:
- Hypoplastic left heart syndrome (HLHS) presents limited surgical options: cardiac transplantation or staged palliation.
- Staged palliation involves the Norwood operation followed by a two-staged Fontan procedure.
Purpose of the Study:
- To describe a 17-year experience with staged palliation for HLHS and its variants.
- To evaluate outcomes and identify factors influencing mortality in HLHS treatment.
Main Methods:
- A cohort of 64 infants with HLHS underwent the Norwood procedure between 1989 and 2006.
- Follow-up data included 143.2 patient-years, with subsequent stages of palliation performed as indicated.
Main Results:
- Early mortality after the Norwood procedure significantly decreased from 39.06% (1989-1999) to 0% (2004-2006).
- Mortality causes included sepsis, capillary leak, and heart failure. Survivors experienced minimal long-term complications.
Conclusions:
- Outcomes in staged palliation for HLHS have improved due to accumulated experience and expertise.
- Lower operative weight, ascending aortic size, and cardiopulmonary bypass duration significantly impact early Norwood procedure mortality.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
